Videos

WATCH: Israeli drug doubles survival time for patients with brain tumors

Professor Dror Harats, M.D., CEO of VBL Therapeutics, describes Phase III clinical trials of a cancer treatment in which a virus is injected intravenously and cuts off blood supply to solid tumors, shrinking cancerous growths.

Share
Published by
Eliyahu Tulshinski
Tags: brain tumors cancer treatment Dror Harats solid tumors VBL Therapeutics virus

Recent Posts

  • Israel News

Defense Minister: The US is blocking us from fighting Iran

Israel's defense minister says Washington is preventing renewed military action against Iran, despite Israeli readiness.

31 minutes ago
  • World News

Explosive audio: Biden admits to keeping classified material

Former president Joe Biden’s attorneys fought to keep the tapes private before a court ordered…

44 minutes ago
  • Videos

WATCH: Iraqi Muslim pilgrims attack posters of Netanyahu and Trump

Dozens of Iraqi Muslims on their pilgrimage to Karbala were seen attacking large posters of…

2 hours ago
  • Analysis & Opinion

Iran’s grip on its Arab proxies remains powerful – opinion

Iran’s enemies have yet to find an effective antidote to the IRGC’s ability to infiltrate…

2 hours ago
  • Israel News

Israeli hospital’s October 7 experience offers lessons for future crises

The study called for stronger coordination between civilian hospitals, emergency services, and military authorities to…

2 hours ago
  • Middle East

Drone attacks target Israel, Jordan, Saudi Arabia and Iraq despite pause in US-Iran fighting

Israel shoots down drones approaching its eastern frontier, with attacks also reported in Jordan, Saudi…

3 hours ago